Clinical Trials Browser

NIH × Urinary Bladder Neoplasms × Neoadjuvant Therapy × Clear all

NCT01222676 2013-08-12

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Phase 2 Unknown

Urinary Bladder Neoplasms